ArticleRheumatology and immunology research2024

Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions.

Mihai Tudor Albu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.